Increasing number of surgical procedures is expected to drive the global swollen knee treatment market during the forecast period

Pune, India, July 2025/MRFR Press Release/- Market Research Future published a half-cooked research report on the global swollen knee treatment market.

Swollen knee treatment market report Highlights

A swollen knee arises when surplus fluid accumulates in or around your knee joint. It is also called as “water on the knee” and “knee effusion”. A swollen knee may be a consequence of overuse injuries, or trauma, and an underlying disease or condition. According to the American Academy of Orthopedic Surgeons, the total knee replacement surgeries is projected to grow by USD 2.12 Billion procedures per year by 2032. The swollen knee treatment market is anticipated to grow due to the rise in geriatric population, obesity, arthritis, and others. Serious complications such as blood clots, knee joint infections can be restraining factors for the growth of the market.

Segmentation

The global swollen knee treatment market has been segmented on the basis of type and end-users. On the basis of type, the market has been classified as medications, patient-controlled analgesia (PCA) pumps, nerve blocks, liposomal bupivacaine, and surgery. The medications have been segmented into opioids and corticosteroids and others. The surgery is segmented into arthrocentesis, arthroscopy and knee replacement. The knee replacement is further segmented into total knee replacement, unicompartmental knee replacement, and others. On the basis of end-users, the market has been classified as hospitals, clinics, ambulatory surgery centers, and others.

Regional Analysis

The Americas is projected to lead the swollen knee treatment market in the forecast period. Rising rate in a number of surgeries due to factors such as accidents, injuries, and others contribute majorly to the growth of the market. Increasing healthcare awareness, advancement in technology, medical tourism, and an increase in disposable income are some other factors that boost the growth of the market.

The European market is expected to hold the second largest market share as osteoarthritis is most common in Germany. The European market is projected to grow because of the increase in elderly population, growing prevalence of diabetes, and obesity in the region.

Asia-Pacific was projected to be the fastest growing region for the global swollen knee treatment market. The market is expected to witness growth owing to the rising patient population, changing lifestyle, and growing elderly population. This is expected to provide favorable backgrounds for the market to grow.

The Middle East and Africa accounts for the least share due to stringent government policies and low per capita income.

Key Players

Some of the key players in the global swollen knee treatment market are Stryker Corporation, Zimmer Holdings, Smith & Nephew Plc., DePuy Companies Inc., Wright Medical Group Inc., Biomet Inc., Exactech, B. Braun Melsungen AG, Pfizer Pharmaceuticals Inc., Merck & Co., Fresenius Kabi, AngioDynamics , C.R.Bard ,Teleflex, and Smiths Medical